Abstract:Human angiostrongyliasis, caused by consuming the larva stage of Angiostrongylus cantonensis , is an infectious disease involving the central nervous system (CNS) and ophthalmic system. Current treatment of angiostrongyliasis involves albendazole accompanied by analgesics and corticosteroids. However, long-term use of corticosteroids may lead to significant adverse effects. In the current study, we screened through different potentially effective flavonoid compounds and identified quercetin as an effective anti-inflammatory agent in an angiostrongyliasis mouse model. Our results identified that quercetin may reverse the neurological defects in mice with angiostrongyliasis. The brain pathology and inflammatory status were also improved by albendazole-quercetin co-therapy. Further analysis showed that albendazole-quercetin co-therapy had a better therapeutic effect than albendazole or quercetin monotherapy. This therapeutic effect was achieved by inhibiting the brain inflammasome activation and apoptosis. Albendazole-quercetin co-therapy also leads to the inhibition of brain IL-5, possibly leading to improved pathology. Our results here proved that quercetin may serve as a potential adjuvant drug in treating human angiostrongyliasis. Human infection following accidental consumption of Angiostrongylus cantonensis can cause eosinophilic meningoencephalitis. Albendazole is the drug of choice for treatment, followed by continuous use of analgesics and corticosteroids, which may have safety concerns. On the other hand, flavonoids are derived from natural plants and have been shown to improve cognitive function by inhibiting the central nervous system (CNS) inflammation. However, the effect of flavonoids combined with albendazole in treating angiostrongyliasis is still unclear. In the current study, we aimed to investigate the therapeutic potential of flavonoids in combination with albendazole for A . cantonensis infection. Our results found that quercetin exhibited the most significant therapeutic effect with albendazole, by which the combined regimen improved the brain histopathology and recovered the mice's neurological functions. This combined therapy also reduces inflammasome activation, pyroptosis, apoptosis, and immune imbalance in the infected mouse brains. Our current study indicated that quercetin possessed the potential as an anti-inflammatory drug and may be helpful in the treatment of A . cantonensis- induced meningoencephalitis.

Curative effects and mechanisms of AG1296 and LY294002 co-therapy in Angiostrongylus cantonensis -induced neurovascular unit dysfunction and eosinophilic meningoencephalitis

Co-Therapy of Albendazole and Dexamethasone Reduces Pathological Changes in the Cerebral Parenchyma of Th-1 and Th-2 Dominant Mice Heavily Infected with Angiostrongylus cantonensis: Histopathological and RNA-seq Analyses

Neuroprotective effects of CysLT2R antagonist on Angiostrongylus cantonensis -induced edema and meningoencephalitis

Improvements of cognitive functions in mice heavily infected by Angiostrongylus cantonensis after treatment with albendazole, dexamethasone, or co-therapy

Antineuroinflammatory and neurotrophic effects of CNTF and C16 peptide in an acute experimental autoimmune encephalomyelitis rat model.

Dose-dependent anti-inflammatory and neuroprotective effects of an α β 3 integrin-binding peptide

In vivo screening of flavonoid compounds revealed quercetin as a potential drug to improve recovery of angiostrongyliasis after albendazole treatment

Defective glycolysis in the cerebrum and cerebellum correlates with the pathology and neurological declines in mice with Angiostrongylus cantonensis infection

Interleukin 17A Derived from γδ T Cell Induces Demyelination of the Brain in Angiostrongylus cantonensis Infection

The therapeutic effect of Tanshinone IIA in mouse astrocytes after treatment with Angiostrongylus cantonensis fifth-stage larval excretory-secretory products

Increased expression of the kynurenine pathway in mice with eosinophilic meningitis caused by Angiostrongylus cantonensis infection

MicroRNA miR-155-5p knockdown attenuates Angiostrongylus cantonensis-induced eosinophilic meningitis by downregulating MMP9 and TSLP proteins

The protective effects of benzaldehyde combined with albendazole against brain injury induced by Angiostrongylus cantonensis infection in mice.

The Protective Effect of Astragalus Polysaccharide on Experimental Autoimmune Encephalomyelitis in Mice by Activating the AMPK/JAK/STAT3/Arginase-1 Signaling Pathway

C16 Peptide Shown to Prevent Leukocyte Infiltration and Alleviate Detrimental Inflammation in Acute Allergic Encephalomyelitis Model

3-Hydroxybenzaldehyde and 4-Hydroxybenzaldehyde enhance survival of mouse astrocytes treated with Angiostrongylus cantonensis young adults excretory/secretory products

A restored humoral environment ameliorates acute brain injury after Angiostrongylus cantonensis infection

C16 Peptide and Angiopoietin-1 Protect Against LPS-induced BV-2 Microglial Cell Inflammation.

Angiopoietin-1 and C16 Peptide Attenuate Vascular and Inflammatory Responses in Experimental Allergic Encephalomyelitis.

IgE antibody responses in cerebrospinal fluids relate to the brain pathologic injury of hosts with Angiostrongylus cantonensis infection

Angong Niuhuang Wan ameliorates LPS-induced cerebrovascular edema by inhibiting blood‒brain barrier leakage and promoting the membrane expression of AQP4